Clinical Trial Update: Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating allogeneic blood stem cell transplantation with adoptive immunotherapy for Hodgkin lymphoma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hodgkin's Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-05-09